The positive safety review from the DSMB enables the trial to move forward as planned, with an estimated completion date in December 2023
This request for withdrawal of the two dossiers was made after necessary consultations and receiving guidance from EMA
Augnito’s AI comprehends all English accents with 99% accuracy
Antimicrobial Resistance (AMR) poses a significant threat to global healthcare systems and patient safety
Effective disaster response and management is a collaborative work
This partnership will revolutionize Pharmarack's digital infrastructure with Snowflake's single, integrated platform to facilitate advanced analytic
Sajjan India Limited is looking for expansion, both organically and through acquisitions, to achieve the planned growth
The company has now received the Establishment Inspection Report (EIR) indicating closure of the inspection
Chinook Therapeutics is a clinical-stage biopharmaceutical company with two high-value, late-stage assets in development for IgA nephropathy (IgAN), a rare, progressive chronic kidney disease
Subscribe To Our Newsletter & Stay Updated
